It works by targeting parts of the brain that regulate appetite. Like liraglutide, semaglutide is FDA approved at a higher dose for the treatment of obesity and at a lower dose for the management ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

New Delhi: A study has found that brain chemicals such as dopamine and serotonin work together in controlling hunger and food ...

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Conditions linked to obesity, such as chronic kidney disease and ... not protected by the blood-brain barrier—and this may ...

Genetics, hormones and variability in how the brain regulates energy can all ... at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. "With such high expectations ...